Patents/Inventors

Yat Sun Or

Waltham, MAUS49 patents

47 Patents

US126124122026
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US125706632026
Crystal Forms of an Anti-sars Cov-2 Agent
Enanta Pharmaceuticals, Inc.
0 cites
US125527772026
Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US125401412026
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US125094702025
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US124962822025
Hepatitis B Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US124798542025
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US124599232025
Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US123981472025
Macrocyclic Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US123847532025
17-beta-hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US123589212025
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US122972092025
Benzodiazepine Derivatives as RSV Inhibitors
Enanta Pharmaceuticals, Inc.
0 cites
US122811402025
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US122686942025
Combination Pharmaceutical Agents as RSV Inhibitors
Enanta Pharmaceuticals, Inc.
0 cites
US122641592025
Functionalized Heterocycles as Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US121628572024
Antiviral Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US121577312024
EIF4E Inhibitors and Uses Thereof
PIC Therapeutics, Inc.
0 cites
US121459422024
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US121459412024
Heterocyclic Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US120544932024
Hepatitis B Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US120180172024
Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US120114252024
Hepatitis B Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US120062912024
Processes for the Preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic Acid
Enanta Pharmaceuticals, Inc.
0 cites
US120063262024
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US119936002024
Saturated Spirocyclics as Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119760842024
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119705022024
Macrocyclic Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119588792024
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US119523892024
Benzodiazepine Derivatives as RSV Inhibitors
Enanta Pharmaceuticals, Inc.
0 cites
US119458302024
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US119458242024
Heterocyclic Compounds as Anti-viral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119199102024
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119127142024
Spiropyrrolidine Derived Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US119126952024
Benzodiazepine Derivatives as RSV Inhibitors
Enanta Pharmaceuticals, Inc.
0 cites
US118913932024
Functionalized Heterocycles as Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US118589452024
Alkyne-containing Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US118344362023
Tetrazole Containing Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US118021252023
Functionalized Heterocyclic Compounds as Antiviral Agents
0 cites
US117607552023
Hepatitis B Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US117534032023
EIF4E Inhibitors and Uses Thereof
PIC Therapeutics, Inc.
0 cites
US117380192023
Substituted Heterocycles as Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US117186412023
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US115966112023
Hepatitis B Antiviral Agents
Enanta Pharmaceuticals, Inc.
0 cites
US115780972023
Tetrazole Derivatives of Bile Acids as FXR/TGR5 Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US115723672023
Antiviral Heterocyclic Compounds
Enanta Pharmaceuticals, Inc.
0 cites
US115603682023
Apoptosis Signal-regulating Kinase 1 Inhibitors and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites
US115550322023
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
Enanta Pharmaceuticals, Inc.
0 cites